Aromatase Inhibitor News and Research

RSS
Aromatase Inhibitors are drugs that prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy for postmenopausal women who have hormone-dependent breast cancer.
Tart cherry reduces joint pain and sore muscles in some breast cancer patients, study shows

Tart cherry reduces joint pain and sore muscles in some breast cancer patients, study shows

Targeted breast cancer therapy shows 'encouraging' results

Targeted breast cancer therapy shows 'encouraging' results

Targeted therapy plus hormone therapy improves survival in premenopausal patients with advanced HR+ breast cancer

Targeted therapy plus hormone therapy improves survival in premenopausal patients with advanced HR+ breast cancer

FRAX tool useful in breast cancer patients treated with aromatase inhibitors

FRAX tool useful in breast cancer patients treated with aromatase inhibitors

FDA extends indication of metastatic breast cancer treatment to include male patients

FDA extends indication of metastatic breast cancer treatment to include male patients

Altering gut microbiome may be potential treatment option for PCOS

Altering gut microbiome may be potential treatment option for PCOS

Neuron-derived estrogen key to making memories

Neuron-derived estrogen key to making memories

Genetic changes may predict likelihood of relapse in breast cancer patients

Genetic changes may predict likelihood of relapse in breast cancer patients

Study: Drug reduces hot flash frequency, improves quality of life in breast cancer survivors

Study: Drug reduces hot flash frequency, improves quality of life in breast cancer survivors

Drugs approved for breast cancer treatment are effective and well tolerated in men

Drugs approved for breast cancer treatment are effective and well tolerated in men

Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients

Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients

Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer

Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer

Age-related estrogen increase may be the culprit behind inguinal hernias in men

Age-related estrogen increase may be the culprit behind inguinal hernias in men

FDA grants approval for first breast cancer drug through 'Real-Time Oncology Review'

FDA grants approval for first breast cancer drug through 'Real-Time Oncology Review'

Study finds combination therapy to be safe, effective for treatment of male infertility

Study finds combination therapy to be safe, effective for treatment of male infertility

QMUL professor receives Cancer Research UK Lifetime Achievement Award

QMUL professor receives Cancer Research UK Lifetime Achievement Award

Astex celebrates as breast cancer drug gets European marketing approval

Astex celebrates as breast cancer drug gets European marketing approval

Aspirin used in “baby” doses may prevent breast cancer, study suggests

Aspirin used in “baby” doses may prevent breast cancer, study suggests

Researchers find link between hormones and inguinal hernias in older men

Researchers find link between hormones and inguinal hernias in older men

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017